Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Mouse Clusterin Biotinylated Antibody, R&D Systems™

Goat Polyclonal Antibody
Supplier: R&D Systems BAF2747
This item is not returnable.
View return policy
Description
Clusterin/APOJ Polyclonal specifically detects Clusterin/APOJ in Mouse samples. It is validated for Western Blot, ELISA Detection (Matched Antibody Pair).Specifications
Clusterin/APOJ | |
Polyclonal | |
Biotin | |
Q06890 | |
Clu | |
Mouse myeloma cell line NS0-derived recombinant mouse Clusterin (R&D Systems, Catalog # 2747-HS) Glu22-Glu448 Accession # Q06890 | |
50 μg | |
Primary | |
Detects mouse Clusterin in ELISAs and Western blots. In Western blots, approximately 10% cross-reactivity with recombinant human Clusterin is observed. | |
Mouse | |
IgG |
Western Blot, ELISA | |
LYOPH | |
Western Blot 0.1 ug/mL, ELISA Detection (Matched Antibody Pair) 0.1-0.4 ug/mL | |
40, 40, sulfated glycoprotein 2, Aging-associated gene 4 protein, aging-associated protein 4, apo-J, APOJ, Apolipoprotein J, CLI, CLIclusterin (complement lysis inhibitor, SP-40, CLU, clusterin, Complement cytolysis inhibitor, complement lysis inhibitor, Complement-associated protein SP-40, Ku70-binding protein 1, KUB1SGP2, MGC24903, NA1/NA2, SGP-2, SP-40, sulfated glycoprotein 2, Testosterone-repressed prostate message 2, testosterone-repressed prostate message 2, apolipoprotein J), TRPM-2, TRPM-2TRPM2 | |
Goat | |
Affinity Purified | |
RUO | |
1191 | |
Reconstitute at 0.2 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction